Skip to main content
T

Tatva Chintan Pharma Chem Limited — Investor Relations & Filings

Ticker · TATVA ISIN · INE0GK401011 LEI · 335800I28VDPT9WEFU68 BSE.NS Manufacturing
Filings indexed 435 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country IN India
Listing BSE.NS TATVA

About Tatva Chintan Pharma Chem Limited

https://www.tatvachintan.com/

Tatva Chintan Pharma Chem Limited specializes in the manufacturing of Structure Directing Agents (SDAs), Phase Transfer Catalysts (PTCs), and electrolyte salts for supercapacitor batteries. The company also produces a diverse range of pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). Its SDAs are essential for the synthesis of zeolites, which find applications in automotive emission control and petrochemical refining. By integrating green chemistry principles into its manufacturing processes, the company provides high-purity products for global markets. Its core competencies include complex chemical synthesis and dedicated research and development, focusing on sustainable solutions for the energy storage, environmental, and life sciences sectors.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-06 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-06 English
Trading Window
Regulatory Filings
2026-03-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-19 English
Updates
Regulatory Filings
2026-03-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.